Articles, App Notes, Case Studies, & White Papers
-
CMC And Regulatory Considerations For CRISPR Therapies
3/21/2024
This article explores the details of Chemistry, Manufacturing, and Controls and Critical Quality Attributes, which play an important role in gene editing.
-
Cell & Gene Therapy In The Asia Pacific Clinical Trial Landscape
1/6/2023
Discover how a new class of therapeutics called cell and gene therapies are revolutionizing how diseases are treated and even potentially cured.
-
The Value Of Peptones For Enhancing Biopharmaceutical Productivity
11/18/2024
Peptones, versatile media additives derived from various sources, offer numerous benefits for biopharmaceutical production.
-
Fast Track RNA-LNP Drug Development By Lowering The Lipid Barrier
8/21/2023
Fast-track RNA-LNP development, streamline screening with off-the-shelf ionizable lipid mixes, and utilize validation strategies to generate reproducible and scalable LNPs for lead candidates.
-
The Current And Future Value Of mRNA Vaccines And Therapeutics
5/16/2024
Discover how decades of research have propelled mRNA technology to the forefront of therapeutic development and learn how our expertise is advancing mRNA drug development.
-
Efficient, Scalable Purification Of mRNA By Affinity Chromatography
6/7/2021
Increasing demand for mRNA as a therapeutic product requires efficient, scalable purification methods. Here, a monolithic stationary phase is used to purify mRNA from a capping mix of Luc2 RNA.
-
Global Prevalence And Clinical Trials Landscape Of AML
4/8/2024
Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
-
Understanding The Microfluidic Platforms For Scaling Nanoparticle Production
10/13/2022
Learn about the benefits of microfluidics for nanoparticle production over traditional methods as well as scaling nanoparticle production for clinical or industrial use.
-
Avoiding The Pitfalls Of LNPs And Complex Formulations
Explore the necessary components of a smooth tech transfer for LNP-based drugs, including the variables that impact LNP formulation and the outsourcing strategies needed to avoid common pitfalls.
-
Development Of LNP Formulations Using The KNAUER NanoScaler
12/6/2024
Lipid nanoparticles (LNPs) offer a robust solution for nucleic acids. The NanoScaler system optimizes this technology, enabling scalable and reproducible LNP formulations for diverse applications.